NCT06937814

The Effect of Humiome® Post LB on Gut COMFort in healthY Adult Volunteers

The Effect of Humiome® Post LB on Gut COMFort in healthY Adult Volunteers: a Double-blind, Randomized Placebo-controlled Study

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 250 (estimated)
• Sponsor: dsm-firmenich Switzerland AG · Industry
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Accepted

Summary

The goal of this double-blind, randomized placebo-controlled study is to evaluate the effect of an 8-week supplementation of Humiome ® Post LB (170 mg) on bowel movements in healthy adult volunteers compared to Placebo adjusted on baseline. The main question\[s\] it aims to answer \[is/are\]: Does Humiome ® Post LB improve bowel movements with self-reported GI issues? Participants will be provided Humiome ® Post LB (170 mg) for 8 weeks and asked to complete a study diary, questionnaires, and stool samples.

Conditions

• GI Issues
• Bowel Movements
• Gastrointestinal Symptoms

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Humiome ® Post LB	Participants will be instructed to take one capsule with a glass of water after the first meal of the day.
OTHER	Placebo	Participants will be instructed to take one capsule with a glass of water after the first meal of the day.

Timeline

• Start date: 2025-06-16
• Primary completion: 2026-04-01
• Completion: 2026-04-01
• First posted: 2025-04-22
• Last updated: 2026-03-09

Locations

1 site across 1 country: Canada